Apr. 2000
Joined Taisho Pharmaceutical Co., Ltd.

May 2000
Joined Abbott Laboratories

Aug. 2006
Corporate Planning Division of Taisho Pharmaceutical Co., Ltd.

Oct. 2006
Director, Assistant to Officer in charge of Prescription Pharmaceutical Operation Group of Taisho Pharmaceutical Co., Ltd.

Oct. 2006
Deputy Head of Sales Headquarters of Taisho Toyama Pharmaceutical Co., Ltd.

Jun. 2007
Member of the Board of Taisho Toyama Pharmaceutical Co., Ltd.

Jun. 2007
Member of the Board of Taisho Pharmaceutical Co., Ltd.

Jun. 2008
Managing Member of the Board

Apr. 2009
Executive Vice President

Oct. 2011
Executive Vice President of the Company

Jun. 2012
Chief Executive Officer (Representative) of Taisho Pharmaceutical Co., Ltd. (present)

Jun. 2013
Member of the Board of the Company

Jun. 2015
Executive Vice President of the Company

Jul. 2024
Chief Executive Officer of the Company（present）

Apr. 1976
Joined The Sumitomo Bank, Limited

Jun. 2003
Executive Officer of Sumitomo Mitsui Banking Corporation

Oct. 2006
Managing Executive Officer

Jun. 2007
Director of Sumitomo Mitsui Financial Group, Inc.

Apr. 2009
Director and Senior Managing Executive Officer of Sumitomo Mitsui Banking Corporation

Apr. 2011
President and Chief Executive Officer

Jun. 2011
Outside Director of NEC Corporation

Apr. 2017
President of Sumitomo Mitsui Financial Group, Inc.

Jun. 2017
Director President

Apr. 2019
Chairman of the Board (present)

Jun. 2019
Member of the Board (Outside) of the Company (present)

Jun. 2020
Outside Director of Komatsu Ltd. (present)

Jun. 2020
Outside Auditor of Nankai Electric Railway Co., Ltd.

Jun. 2021
Outside Director/Audit & Supervisory Committee Member (present)

Apr. 1975
Admitted to the bar (Dai-Ichi Tokyo Bar Association)Joined Ozaki & Momo-o

May. 1978
Graduated from Columbia University, Law School

Aug. 1978
Joined Weil, Gotshal & Manges LLP in New York

Mar. 1979
Admitted to the New York Bar

Apr. 1989
Founded Momo-o, Matsuo & Namba
Partner of Momo-o, Matsuo & Namba (present)

Apr. 1997
Lecturer at Nihon University, College of Law: International Transaction Law

Jun. 1999
External Corporate Auditor of Victor Company of Japan, Limited

Jun. 2000
External Corporate Auditor of Billing System Corporation

Jun. 2003
External Corporate Auditor of Yamanouchi Pharmaceutical Co., Ltd.

Jun. 2004
External Director of Yamanouchi Pharmaceutical Co., Ltd.

Apr. 2005
Lecturer at Hitotsubashi University, Faculty and Graduate School of Law: World Business Law

Jun. 2007
External Director of CAPCOM CO., LTD.

Oct. 2008
External Director of JVC KENWOOD Holdings, Inc.

Jun. 2009
Outside Corporate Auditor of Toray Industries, Inc.

Mar. 2014
External Corporate Auditor of Solasia Pharma K.K.

Mar. 2015
Outside Director of TonenGeneral Sekiyu K.K.

Jun. 2016
External Director [Member of the Audit and Supervisory Committee] of CAPCOM CO., LTD.

Jun. 2018
Outside Statutory Auditor of Sumitomo Forestry Co., Ltd. (present)

Apr. 2020
Provisional Audit & Supervisory Board Member of the Company

Jun. 2020
Audit & Supervisory Board Member (Outside) of the Company

Aug. 2022
Outside Director of Rapidus Corporation

Mar. 2023
Director (present)

Jul. 2024
Member of the Board (Outside) of the Company (present)

Apr. 1976
Joined Taisho Pharmaceutical Co., Ltd.

Nov. 2000
Manager of First Research Office for Pharmaceutical Development

Apr. 2001
Manager of Research Office for Medicinal Chemistry

Feb. 2003
Manager of Pharmaceutical Quality Assurance Promotion Office

Apr. 2004
Director and Head of Quality Assurance Headquarters

Apr. 2008
Corporate Officer and Head of Pharmaceutical and Chemicals Research Center

Jul. 2008
Deputy Head of Research Headquarters

Apr. 2010
Head of Quality Assurance Headquarters

Apr. 2015
Corporate Officer of the Company

Jun. 2015
Member of the Board of the Company

Jun. 2015
Member of the Board of Taisho Pharmaceutical Co., Ltd.

Apr. 2016
Member of the Board, Executive Officer of Taisho Pharmaceutical Co., Ltd.

Jun. 2019
Audit & Supervisory Board Member of the Company (present)

Jun. 2019
Audit & Supervisory Board Member of Taisho Pharmaceutical Co., Ltd. (present)

Apr. 1981
Joined NEC Corporation

Sep. 1995
Joined Sofmap Co., Ltd.

Apr. 1998
Joined Taikisha Ltd.

Jan. 2005
Joined Taisho Pharmaceutical Co., Ltd.

Apr. 2019
General Manager of Corporate Auditors' Office of the Company

Apr. 2019
General Manager of Corporate Auditors' Office of Taisho Pharmaceutical Co., Ltd.

Jun. 2021
Audit & Supervisory Board Member of the Company (present)

Jun. 2021
Audit & Supervisory Board Member of Taisho Pharmaceutical Co., Ltd. (present)

Mar. 1974
Executive Director and General Manager of Products Division

Jan. 1982
Managing Director and Head of Products Headquarters

Oct. 1984
Managing Director and Head of Central Sales Headquarters

Jan. 1994
President (Representative) of AIM CREATE Co., Ltd.

Apr. 1997
President (Representative) of MOVING CO., LTD.

Apr. 2006
Adviser

Jan. 2010
President (Representative) of Toyoshima Kogyo Co., Ltd. (current: A-TOM Co., Ltd.)

Jun. 2015
Audit & Supervisory Board Member (Outside) of the Company (present)

May. 2019
Chairman (Representative) of A-TOM Co., Ltd. (present)

Apr. 1988
Completed the Supreme Court Judicial Training Institute (40th class)
Joined Tomotsune Kimura Mitomi Law Office

Jun. 1993
Harvard Law School (LL.M.)

Jun. 1993
Worked for Bechtel Corporation in Mr./Ms., USA

Sep. 1993
Worked at Cravath, Swaine & Moore LLP in New York, USA

Sep. 1994
Returned to Tomotsune Kimura Mitomi Law Office

Jan. 1996
Appointed as a partner of the firm

2004
Standing Committee Member of the Study Group on Domestic Legislative Issues Concerning the Collective Action Clause

Jan. 2005
Became a partner of Anderson Mori & Tomotsune Law Office (currently Anderson Mori & Tomotsune Law Office Foreign Law Joint Venture)(present)

Jul. 2005
Adjunct Lecturer, Chuo University Law School (Part-time Lecturer)

Apr. 2007
Visiting Lecturer, Chuo University Law School

Apr. 2013
Visiting Professor, Chuo University Law School

Jul. 2024
Audit & Supervisory Board Member (Outside) of the Company (present)